Michigan Mouse Metabolic Phenotyping Center
密歇根小鼠代谢表型中心
基本信息
- 批准号:10411881
- 负责人:
- 金额:$ 54.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-02 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:16S ribosomal RNA sequencingAnaerobic BacteriaAnimalsAreaAtherosclerosisAwardBehaviorBiochemicalBioinformaticsBiologicalBiological AssayBiological ModelsBlindnessBlood PressureBlood VesselsCardiacCardiovascular PhysiologyCardiovascular systemCaringClinical ChemistryCollaborationsComplications of Diabetes MellitusCulex (Genus)DataData SetDatabasesDevelopmentDiabetes MellitusDiabetic AngiopathiesDiseaseEchocardiographyEducational workshopElectrocardiogramEndocrineExercise ToleranceFosteringFunctional disorderFundingGastrectomyGenerationsGenesGenomicsGerm-FreeGlucoseGlucose ClampGnotobioticGoalsGrantHealth Care CostsHealthcareHeart failureHistopathologyHomeostasisHormone secretionHousingHumanImageIn VitroIndirect CalorimetryInstitutionKidney DiseasesKidney FailureLaboratoriesLeadershipLibrariesLiquid substanceLiteratureMaintenanceMeasurementMetabolicMetabolic DiseasesMetabolismMichiganMicrovascular DysfunctionModelingMotor ActivityMouse StrainsMusMyocardial IschemiaNeuropathyObesityOperant ConditioningPathogenesisPatternPhenotypePhysiologicalPhysiologyProtocols documentationPublishingReproducibilityResearchResearch PersonnelResourcesRetinal DiseasesRewardsRibosomesSamplingSensitivity and SpecificityServicesSurgical ModelsTelemetryTestingTissuesTraining ProgramsUltrasonographyUniversitiesWild Type Mouseanimal carebariatric surgerybehavior measurementbiobehaviorblood glucose regulationburden of illnesscostdiabeticdietaryexperienceglucose tolerancegut microbiomehuman modelin vivoinsulin toleranceknowledge basemacrovascular diseasemedical schoolsmembermetabolic phenotypemicrobialmicrobial genomemicrobiomemicrobiome analysismouse modelnerve damagenoveloperationphenotypic datapressureprogramstooltraining opportunitytranscriptome sequencingtranscriptomicstransmission process
项目摘要
Project Summary / Abstract – Overall
Metabolic disorders and their vascular complications are among the most pressing healthcare issues
worldwide. The University of Michigan Medical School has strategically invested in both human and physical
resources over the past 15 years under the umbrella of the Michigan Comprehensive Diabetes Center in a
concerted attack on this problem. One component of the strategy has been to foster the development of core
laboratories within the university to provide key expertise and specialized phenotyping services at reasonable
cost to researchers throughout the institution. We now propose to coalesce a quartet of these phenotyping
cores into the Michigan MMPC to continue providing comprehensive and state of the art services internally,
while expanding their availability to researchers on a national level, and continuing the development of more
sensitive and more specific tools to probe the pathogenesis and biochemical consequences of diabetes and
obesity in mouse models. The Michigan MMPC will provide services in four major areas. The Metabolism,
Bariatric Surgery and Behavior Core will perform a variety of in vivo physiological assessments encompassing
glucose homeostasis (glucose tolerance, insulin tolerance, hyperinsulinemic/euglycemic clamps), energy
homeostasis (indirect calorimetry by CLAMS, dietary challenge), ultradian hormone secretion (Culex platform
for serial biological fluid sampling from unrestrained mice), behavioral measurements (locomotor activity, meal
pattern analysis, operant conditioning) and generation of bariatric surgery models. The Cardiovascular
Pathophysiology Core will assess cardiovascular function (exercise tolerance, blood pressure, ECG, telemetry,
echocardiogram), offer mouse surgical models of cardiac ischemia and pressure overload and imaging using
ultrasound. The Microvascular Complications Core will provide basic and advanced assessment of diabetes
complications including neuropathy, nephropathy, and retinopathy. The Microbiome Core will provide
anaerobic microbial culture, microbiome genomic and transcriptomic libraries, 16S ribosomal gene and RNA
sequencing with associated bioinformatic analysis. Mouse importation, housing, veterinary care, clinical
chemistry and histopathology services will be provided by the Animal Care Core. In addition, the latter core
hosts a germ-free mouse facility and will interact with the Microbiome core to produce and distribute germ-free
and gnotobiotic mouse models. The Administrative Core will manage all Center activities, oversee financial
operations, provide training opportunities, and collaborate with the other phenotyping centers and the Central
Coordinating and Bioinformatics Unit of the MMPC Consortium by providing all collected phenotyping data and
protocols and participating in the Pilot and Feasibility award and MICROMouse funding programs. Together,
our Core resources will provide in a single Center access to a broad range of advanced phenotyping
capabilities, including our unique focus and expertise on microvascular complications, microbiome analysis
and germ-free mice and bariatric surgery models.
项目总结/摘要——总体
代谢紊乱及其血管并发症是最紧迫的医疗保健问题之一
密歇根大学医学院在全球范围内对人类和身体进行了战略投资。
过去 15 年在密歇根综合糖尿病中心的保护下的资源
该战略的一个组成部分就是促进核心技术的发展。
大学内的实验室以合理的价格提供关键专业知识和专业表型服务
我们现在建议合并这些表型分析的四个部分。
核心进入密歇根 MMPC,继续在内部提供全面且最先进的服务,
同时在全国范围内扩大研究人员的可用性,并继续开发更多
敏感和更具体的工具来探讨糖尿病的发病机制和生化后果
密歇根 MMPC 将在代谢、肥胖等四个主要领域提供服务。
减肥手术和行为核心将进行各种体内生理评估,包括
葡萄糖稳态(葡萄糖耐量、胰岛素耐量、高胰岛素/正常血糖钳夹)、能量
体内平衡(通过 CLAMS 间接测热、饮食挑战)、超电激素分泌(Culex 平台
用于从不受约束的小鼠中连续采集生物液体样本)、行为测量(运动活动、进餐
模式分析、操作条件反射)和减肥手术模型的生成。
病理生理学核心将评估心血管功能(运动耐量、血压、心电图、遥测、
超声心动图),提供心脏缺血和压力超负荷的小鼠手术模型以及使用成像
微血管并发症核心将提供糖尿病的基本和高级评估。
微生物组核心将提供包括神经病、肾病和视网膜病在内的并发症。
厌氧微生物培养、微生物基因组和转录组文库、16S 核糖体基因和 RNA
测序及相关的生物信息学分析。小鼠输入、饲养、兽医护理、临床。
此外,动物护理核心将提供化学和组织病理学服务。
拥有无菌小鼠设施,并将与微生物组核心互动以生产和分销无菌产品
行政核心将管理中心的所有活动,监督财务。
操作,提供培训机会,并与其他表型中心和中央合作
MMPC 联盟的协调和生物信息学单位提供所有收集的表型数据和
协议并参与试点和可行性奖以及 MICROMuse 资助计划。
我们的核心资源将在一个中心提供广泛的高级表型分析
能力,包括我们对微血管并发症、微生物组分析的独特关注和专业知识
以及无菌小鼠和减肥手术模型。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carol Fuzeti Elias其他文献
Carol Fuzeti Elias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carol Fuzeti Elias', 18)}}的其他基金
Metabolic Phenotyping in Live Models of Obesity and Diabetes
肥胖和糖尿病活体模型的代谢表型分析
- 批准号:
10588794 - 财政年份:2023
- 资助金额:
$ 54.35万 - 项目类别:
Sex-specific role of androgen signaling in neuroendocrine-behavior interface
雄激素信号在神经内分泌行为界面中的性别特异性作用
- 批准号:
10659301 - 财政年份:2023
- 资助金额:
$ 54.35万 - 项目类别:
Prenatal photoperiod action in hypothalamic development
下丘脑发育中的产前光周期作用
- 批准号:
10700966 - 财政年份:2022
- 资助金额:
$ 54.35万 - 项目类别:
Prenatal photoperiod action in hypothalamic development
下丘脑发育中的产前光周期作用
- 批准号:
10509412 - 财政年份:2022
- 资助金额:
$ 54.35万 - 项目类别:
相似国自然基金
厌氧菌藻生物膜降解噻唑化合物的氢营养代谢机理研究
- 批准号:52300043
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道厌氧菌产新颖鞘磺脂及其免疫调节活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微氧环境下兼性厌氧菌和产甲烷菌降解长链脂肪酸的协同机制
- 批准号:52170037
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
兼性厌氧菌JPG1在不同氧条件下对铜胁迫的抗性机制与调控
- 批准号:52070037
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
肠道厌氧菌S.Moorei通过抑制AGK调节浸润性CD8+T细胞糖酵解增强直肠癌的辐射抵抗及机制
- 批准号:82073329
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
- 批准号:
10818835 - 财政年份:2023
- 资助金额:
$ 54.35万 - 项目类别:
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
- 批准号:
10573109 - 财政年份:2023
- 资助金额:
$ 54.35万 - 项目类别:
Swallowable smart capsule for targeted gastrointestinal microbiome sampling
用于靶向胃肠道微生物组采样的可吞咽式智能胶囊
- 批准号:
10642943 - 财政年份:2022
- 资助金额:
$ 54.35万 - 项目类别:
Swallowable smart capsule for targeted gastrointestinal microbiome sampling
用于靶向胃肠道微生物组采样的可吞咽式智能胶囊
- 批准号:
10425078 - 财政年份:2022
- 资助金额:
$ 54.35万 - 项目类别:
Impact of gut microbial metabolism on host breath volatiles
肠道微生物代谢对宿主呼吸挥发物的影响
- 批准号:
10312570 - 财政年份:2021
- 资助金额:
$ 54.35万 - 项目类别: